Eyesaline Concentrate

Manufacturer
Honeywell Safety Products USA, Inc | Keystone Industries
Effective date
2024-05-27
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 21:01:58

Label at a glance#

ProductEyesaline Concentrate
Active ingredientWATER
Label structure9 sections

Indications and uses

For flushing or irrigating the eye to remove loose foreign material, air pollutants, or chlorinated water.

Dosage and administration

Concentrate must be diluted (1) part concentrate to (10) parts potable water before use Prepare sufficient quantity of constituted eyewash solution in advance of an emergency Mix concentrate with potable water to prepare eyewash solution as follows: Determine quantity of eyewash solution required Follow sanitary procedures Wear protective eyewear and gloves Pour 1/3 of required amount of potable water into mixing ...

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Purified water 92.14%

Purpose

OTC - PURPOSE SECTION

Eyewash

Uses

INDICATIONS & USAGE SECTION

  • For flushing or irrigating the eye to remove loose foreign material, air pollutants, or chlorinated water.

Warnings

WARNINGS SECTION

For external use only- Obtain immidiate medical treatment for all open wounds in or near the eyes.

Do not use

OTC - DO NOT USE SECTION

  • in concentrated form
  • while wearing contact lenses
  • if solution changes color or becomes cloudy
  • for injection
  • in intraocular surgery
  • internally
  • if eye is lacerated or object is embedded
  • if seal is broken

Stop use and consult a doctor if you have

OTC - STOP USE SECTION

  • changes in vision
  • continued reddness, irritation or pain, or if the condition worsens or persists

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Concentrate must be diluted (1) part concentrate to (10) parts potable water before use
  • Prepare sufficient quantity of constituted eyewash solution in advance of an emergency
  • Mix concentrate with potable water to prepare eyewash solution as follows:
  • Determine quantity of eyewash solution required
  • Follow sanitary procedures
  • Wear protective eyewear and gloves
  • Pour 1/3 of required amount of potable water into mixing container or eyewash unit
  • Add 1/3 of required amount of concentrate into water
  • Agitate or mix thoroughly
  • ​Repeat until required amount of solution is prepared
  • Properly dispose of empty bottle after use

Do not reuse.

  • Replace solution no longer than (6) months after mixing

Other information

OTHER SAFETY INFORMATION

  • Do not freeze

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, edetate disodium, sodium chloride, sodium phosphate dibasic, sodium phosphate monobasic

Questions?

OTC - QUESTIONS SECTION

Call 1-800-430-5490

Honeywell Safety Products USA, Inc. 855 S. Mint Street, Charlotte, NC, 28202

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EyesalineEyesaline

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0498-06010498-0601-18, 0498-0601-19

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
28eefeda-a7fb-7d20-e063-6394a90a3476ad430082-6270-033c-e053-2995a90a10062024-12-10WarningsExact identifier
spl set id: ad430082-6270-033c-e053-2995a90a1006

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.